Cargando…

Salivary gland LAMP3 mRNA expression is a possible predictive marker in the response to hydroxychloroquine in Sjögren’s disease

Hydroxychloroquine (HCQ) is a lysosomotropic agent that is commonly used for treating Sjögren’s disease (SjD). However, its efficacy is controversial because of the divergent response to the drug among patients. In a subgroup of SjD patients, lysosome-associated membrane protein 3 (LAMP3) is elevate...

Descripción completa

Detalles Bibliográficos
Autores principales: Nakamura, Hiroyuki, Tanaka, Tsutomu, Ji, Youngmi, Zheng, Changyu, Afione, Sandra A., Warner, Blake M., Oliveira, Fabiola Reis, Motta, Ana Carolina F., Rocha, Eduardo M., Noguchi, Masayuki, Atsumi, Tatsuya, Chiorini, John A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9949663/
https://www.ncbi.nlm.nih.gov/pubmed/36821638
http://dx.doi.org/10.1371/journal.pone.0282227
_version_ 1784892993952546816
author Nakamura, Hiroyuki
Tanaka, Tsutomu
Ji, Youngmi
Zheng, Changyu
Afione, Sandra A.
Warner, Blake M.
Oliveira, Fabiola Reis
Motta, Ana Carolina F.
Rocha, Eduardo M.
Noguchi, Masayuki
Atsumi, Tatsuya
Chiorini, John A.
author_facet Nakamura, Hiroyuki
Tanaka, Tsutomu
Ji, Youngmi
Zheng, Changyu
Afione, Sandra A.
Warner, Blake M.
Oliveira, Fabiola Reis
Motta, Ana Carolina F.
Rocha, Eduardo M.
Noguchi, Masayuki
Atsumi, Tatsuya
Chiorini, John A.
author_sort Nakamura, Hiroyuki
collection PubMed
description Hydroxychloroquine (HCQ) is a lysosomotropic agent that is commonly used for treating Sjögren’s disease (SjD). However, its efficacy is controversial because of the divergent response to the drug among patients. In a subgroup of SjD patients, lysosome-associated membrane protein 3 (LAMP3) is elevated in expression in the salivary glands and promotes lysosomal dysregulation and lysosome-dependent apoptotic cell death. In this study, chloroquine (CQ) and its derivative HCQ were tested for their ability to prevent LAMP3-induced apoptosis, in vitro and on a mouse model of SjD. In addition, efficacy of HCQ treatment was retrospectively compared between high LAMP3 mRNA expression in minor salivary glands and those with LAMP3 mRNA levels comparable with healthy controls. Study results show that CQ treatment stabilized the lysosomal membrane in LAMP3-overexpressing cells via deactivation of cathepsin B, resulting in decreased apoptotic cell death. In mice with established SjD-like phenotype, HCQ treatment also significantly decreased apoptotic cell death and ameliorated salivary gland hypofunction. Retrospective analysis of SjD patients found that HCQ tended to be more effective in improving disease activity index, symptom severity and hypergammaglobulinemia in patients with high LAMP3 expression compared those with normal LAMP3 expression. Taken together, these findings suggested that by determining salivary gland LAMP3 mRNA level, a patient’s response to HCQ treatment could be predicted. This finding may provide a novel strategy for guiding the development of more personalized medicine for SjD.
format Online
Article
Text
id pubmed-9949663
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-99496632023-02-24 Salivary gland LAMP3 mRNA expression is a possible predictive marker in the response to hydroxychloroquine in Sjögren’s disease Nakamura, Hiroyuki Tanaka, Tsutomu Ji, Youngmi Zheng, Changyu Afione, Sandra A. Warner, Blake M. Oliveira, Fabiola Reis Motta, Ana Carolina F. Rocha, Eduardo M. Noguchi, Masayuki Atsumi, Tatsuya Chiorini, John A. PLoS One Research Article Hydroxychloroquine (HCQ) is a lysosomotropic agent that is commonly used for treating Sjögren’s disease (SjD). However, its efficacy is controversial because of the divergent response to the drug among patients. In a subgroup of SjD patients, lysosome-associated membrane protein 3 (LAMP3) is elevated in expression in the salivary glands and promotes lysosomal dysregulation and lysosome-dependent apoptotic cell death. In this study, chloroquine (CQ) and its derivative HCQ were tested for their ability to prevent LAMP3-induced apoptosis, in vitro and on a mouse model of SjD. In addition, efficacy of HCQ treatment was retrospectively compared between high LAMP3 mRNA expression in minor salivary glands and those with LAMP3 mRNA levels comparable with healthy controls. Study results show that CQ treatment stabilized the lysosomal membrane in LAMP3-overexpressing cells via deactivation of cathepsin B, resulting in decreased apoptotic cell death. In mice with established SjD-like phenotype, HCQ treatment also significantly decreased apoptotic cell death and ameliorated salivary gland hypofunction. Retrospective analysis of SjD patients found that HCQ tended to be more effective in improving disease activity index, symptom severity and hypergammaglobulinemia in patients with high LAMP3 expression compared those with normal LAMP3 expression. Taken together, these findings suggested that by determining salivary gland LAMP3 mRNA level, a patient’s response to HCQ treatment could be predicted. This finding may provide a novel strategy for guiding the development of more personalized medicine for SjD. Public Library of Science 2023-02-23 /pmc/articles/PMC9949663/ /pubmed/36821638 http://dx.doi.org/10.1371/journal.pone.0282227 Text en https://creativecommons.org/publicdomain/zero/1.0/This is an open access article, free of all copyright, and may be freely reproduced, distributed, transmitted, modified, built upon, or otherwise used by anyone for any lawful purpose. The work is made available under the Creative Commons CC0 (https://creativecommons.org/publicdomain/zero/1.0/) public domain dedication.
spellingShingle Research Article
Nakamura, Hiroyuki
Tanaka, Tsutomu
Ji, Youngmi
Zheng, Changyu
Afione, Sandra A.
Warner, Blake M.
Oliveira, Fabiola Reis
Motta, Ana Carolina F.
Rocha, Eduardo M.
Noguchi, Masayuki
Atsumi, Tatsuya
Chiorini, John A.
Salivary gland LAMP3 mRNA expression is a possible predictive marker in the response to hydroxychloroquine in Sjögren’s disease
title Salivary gland LAMP3 mRNA expression is a possible predictive marker in the response to hydroxychloroquine in Sjögren’s disease
title_full Salivary gland LAMP3 mRNA expression is a possible predictive marker in the response to hydroxychloroquine in Sjögren’s disease
title_fullStr Salivary gland LAMP3 mRNA expression is a possible predictive marker in the response to hydroxychloroquine in Sjögren’s disease
title_full_unstemmed Salivary gland LAMP3 mRNA expression is a possible predictive marker in the response to hydroxychloroquine in Sjögren’s disease
title_short Salivary gland LAMP3 mRNA expression is a possible predictive marker in the response to hydroxychloroquine in Sjögren’s disease
title_sort salivary gland lamp3 mrna expression is a possible predictive marker in the response to hydroxychloroquine in sjögren’s disease
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9949663/
https://www.ncbi.nlm.nih.gov/pubmed/36821638
http://dx.doi.org/10.1371/journal.pone.0282227
work_keys_str_mv AT nakamurahiroyuki salivaryglandlamp3mrnaexpressionisapossiblepredictivemarkerintheresponsetohydroxychloroquineinsjogrensdisease
AT tanakatsutomu salivaryglandlamp3mrnaexpressionisapossiblepredictivemarkerintheresponsetohydroxychloroquineinsjogrensdisease
AT jiyoungmi salivaryglandlamp3mrnaexpressionisapossiblepredictivemarkerintheresponsetohydroxychloroquineinsjogrensdisease
AT zhengchangyu salivaryglandlamp3mrnaexpressionisapossiblepredictivemarkerintheresponsetohydroxychloroquineinsjogrensdisease
AT afionesandraa salivaryglandlamp3mrnaexpressionisapossiblepredictivemarkerintheresponsetohydroxychloroquineinsjogrensdisease
AT warnerblakem salivaryglandlamp3mrnaexpressionisapossiblepredictivemarkerintheresponsetohydroxychloroquineinsjogrensdisease
AT oliveirafabiolareis salivaryglandlamp3mrnaexpressionisapossiblepredictivemarkerintheresponsetohydroxychloroquineinsjogrensdisease
AT mottaanacarolinaf salivaryglandlamp3mrnaexpressionisapossiblepredictivemarkerintheresponsetohydroxychloroquineinsjogrensdisease
AT rochaeduardom salivaryglandlamp3mrnaexpressionisapossiblepredictivemarkerintheresponsetohydroxychloroquineinsjogrensdisease
AT noguchimasayuki salivaryglandlamp3mrnaexpressionisapossiblepredictivemarkerintheresponsetohydroxychloroquineinsjogrensdisease
AT atsumitatsuya salivaryglandlamp3mrnaexpressionisapossiblepredictivemarkerintheresponsetohydroxychloroquineinsjogrensdisease
AT chiorinijohna salivaryglandlamp3mrnaexpressionisapossiblepredictivemarkerintheresponsetohydroxychloroquineinsjogrensdisease